Si (gp) L.p. Crestline is 10% at Juno Therapeutics, Inc. (JUNO). They have made 1 open-market trade across 1 company since 2014, most recently 2014-12-23.
CIK 0001626597
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $15.6M since 2014, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| JUNO | 988,398 | $86.0M |
Shares reported on the most recent Form 4, priced at the 2014-12-23 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| JUNO | BUY | 2014-12-19 | 2014-12-23 | $25.00 | $15.6M | -18.7% | +1.3% | +1.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.